On November 18, 2020 NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, reported its participation in the virtual 32nd Annual Piper Sandler Healthcare conference, which takes place December 1-3, 2020 (Press release, NantKwest, NOV 18, 2020, https://ir.nantkwest.com/news-releases/news-release-details/nantkwest-participate-32nd-annual-piper-sandler-healthcare?field_nir_news_date_value[min]= [SID1234571353]). NantKwest Executive Chairman Patrick Soon-Shiong, M.D., and Chief Executive Officer Rich Adcock will participate in institutional investor meetings on Tuesday, December 1; meetings may be requested through Piper Sandler.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Additionally, a pre-recorded fireside chat with Dr. Soon-Shiong and Mr. Adcock will be accessible beginning November 23, 2020 on the Piper Sandler conference site and in the Investors section of NantKwest’s website, NantKwest.com. The recording will be available on the NantKwest website through December 31, 2020.